|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
September 02, 2006
"Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.":
Loss of interhemispheric inhibition in patients with MS is related to corpus callosum atrophy [Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK.] "....Interhemispheric physiological inhibition thus is impaired in patients with MS, potentially contributing to impairment of motor control. This work suggests one way in which FMRI monitoring of the transcallosal interactions in motor cortex could become a tool for evaluation of therapies that may enhance function in reversibly impaired pathways. |